Concurrent Session 4D - Part 1: Justice Health | Part 2: Prescription Opioid Treatment - LAIB Post Release
Tracks
Track 4
Thursday, October 31, 2024 |
3:30 PM - 5:00 PM |
Nicholls |
Details
Chair:Nicholas Lintzeris, SESLHD
Speaker
Dr Thileepan Naren
Addiction Medicine Specialist
Western Health
National Prison Addiction Medicine Network
3:30 PM - 3:40 PMBiography
Dr Thileepan Naren is an Addiction Medicine Specialist and General Practitioner with a history of working with disadvantaged and marginalised groups. He has special interests in Aboriginal health, custodial health, public health policy and medical governance. He works across Western Health, cohealth Health Works and the Dame Phyllis Frost Centre.
Mrs Tristan O'Connor
Justice Services Manager
Karralika Programs
Solaris Therapeutic Community: Treatment in prison
3:40 PM - 3:45 PMBiography
Ms Tristan O'Connor is the Justice Services Manager at Karralika Programs. Starting her career in mental health and disability and then moving across to the alcohol and other drug sector 8 years ago, Tristan has a passion for social justice, access and equity for those most vulnerable in our communities.
Dr Joss O'Loan
Director
Kombi Clinic
Reduction in hepatitis C virus prevalence following three high intensity point-of-care HCV testing campaigns in a prison setting in Queensland, Australia
3:45 PM - 3:50 PMBiography
Dr Joss O’Loan is a GP working at Medeco Inala as well as an Advanced Addiction Trainee at Metro South Drug and Alcohol clinic. His favorite place to work however, is delivering HepC care from a Yellow Kombi Van as part of the Kombi clinic, which he co-founded in 2017.
Ms Krysia Keefe
Justice Services Counsellor
Karralika Programs
Karralika Justice Services Counselling: Reflection on practice
3:50 PM - 3:55 PMBiography
Krysia Keefe has post graduate counselling qualifications and a long-lasting passion to work in the AOD sector. Over her 10+ years in the AOD sector she has completed further qualifications in working with people with criminogenic histories, behaviours and complex traumas. Krysia is lead Counsellor of Karralika's Justice Counselling Service.
APSAD 2024
Session Q&A
3:55 PM - 4:00 PMBiography
Dr Bethany White
Senior Research Manager
Edith Collins Centre, Sydney Local Health District
SYMPOSIUM: Retention in opioid against treatment following release from custody: impact of long-acting injectable buprenorphine in the post-release period (The Release Study)
4:00 PM - 5:00 PMBiography
Dr Bethany White is Senior Research Manager, Edith Collins Centre, Sydney Local Health District and Clinical Senior Lecturer, Specialty of Addiction Medicine, Faculty of Medicine and Health, University of Sydney. She has over 20 years research experience in the drug and alcohol field; and she coordinated the Release Study.
Professor Adrian Dunlop
Director, Senior Staff Specialist, Drug & Alcohol Clinical Servcies
Hunter New England Local Health District
What can community opioid treatment programs data tell us about the impact of long-acting depot buprenorphine on the high-risk post-release period for people with opioid dependence?
4:05 PM - 4:15 PMBiography
Dr Bethany White
Senior Research Manager
Edith Collins Centre, Sydney Local Health District
Post-release experiences of people released on long-acting injectable buprenorphine and methadone
4:15 PM - 4:25 PMBiography
Dr Bethany White is Senior Research Manager, Edith Collins Centre, Sydney Local Health District and Clinical Senior Lecturer, Specialty of Addiction Medicine, Faculty of Medicine and Health, University of Sydney. She has over 20 years research experience in the drug and alcohol field; and she coordinated the Release Study.
Ms Lucy Peck
Research Officer
Sydney Local Health District
Long-acting injectable buprenorphine in the post-release period: Factors influencing treatment cessation or formulation change
4:25 PM - 4:35 PMBiography
Ms Lucy Peck is a Research Officer employed by Sydney Local Health District at the Edith Collins Centre. Lucy has been working in the drug and alcohol space for almost six years and is currently coordinating the Cannabidiol for Cannabis Use Disorder trial at the Royal Prince Alfred Site.
Mr Samuel Lawson
Research Officer
NSW Health
Exploring barriers and enablers of long-acting injectable buprenorphine in a post-release patient population: community opioid treatment program staff perspectives
4:35 PM - 4:45 PMBiography
Samuel Lawson is a Research Officer with over 8 years of experience in health behaviour and drug and alcohol research. Sam’s research experience includes working with drug and alcohol populations, regional and rural communities and those experiencing chronic illnesses.
APSAD 2024
Discussion
4:45 PM - 5:00 PMBiography
Chair
Nicholas Lintzeris
Senior Staff Specialist
SESLHD